R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL ：a Multicenter Phase Ib/II Stuty

Condition:   Primary Central Nervous System Lymphoma Interventions:   Drug: Methotrexate;   Drug: Rituximab;   Drug: Lenalidomide Sponsors:   Peking Union Medical College Hospital;   Beijing Tiantan Hospital;   Xuanwu Hospital, Beijing;   Peking University Third Hospital;   Beijing Hospital;   Peking University First Hospital;   Chinese PLA General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials